NeuroSense Therapeutics (NRSN) to Release Quarterly Earnings on Wednesday

Chronological Source Flow
Back

AI Fusion Summary

NeuroSense Therapeutics (NRSN) will report Q4 2025 earnings on March 25, expecting a loss of $0.1050 per share. The stock trades near $0.82, below its 50‑day MA of $0.93. Investors should monitor the upcoming earnings call on April 6.
18/03 08:14 defenseworld.net
4 Πηγές
18/03 08:36 defenseworld.net
18/03 08:36 defenseworld.net
18/03 08:36 defenseworld.net
Comments
Loading...
0